The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia.
Philadelphia (Ph) chromosome negative chronic myeloid leukemia (CML) can be distinguished from clinically similar disorders on the basis of the presence of rearrangement of the breakpoint cluster region (bcr) of chromosome 22. We have identified six patients with Ph-negative CML, each with bcr rearrangement. Apparently normal karyotypes were observed in two cases, and a third contained a rearrangement that did not appear to involve chromosomes 9 or 22. The other three cases had translocations involving chromosome band 9q34 but no case contained the common derivative chromosome 9pter----9q34::22q11----22qter. One case appeared to contain either a deletion of an unrearranged bcr locus in approximately 50% of cells or duplication of rearranged bcr, both 5' and 3' of the chromosome 22 breakpoint. Considerable complexity exists in the types of genetic changes that can juxtapose bcr and the c-abl oncogene in CML. Based on the molecular and cytogenetic analyses of these and other cases described in the literature, we conclude that most cases of true Ph-negative CML arise from submicroscopic genetic exchanges rather than masking of simple t(9;22)(q34;q11) translocations by secondary rearrangements.
Weinstein
M E
ME
Lifecodes Corporation, Valhalla, NY 10595.
Grossman
A
A
Perle
M A
MA
Wilmot
P L
PL
Verma
R S
RS
Silver
R T
RT
Arlin
Z
Z
Allen
S L
SL
Amorosi
E
E
Waintraub
S E
SE
D000328:Adult; D000368:Aged; D002871:Chromosome Banding; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D007621:Karyotyping; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D005810:Multigene Family; D011519:Proto-Oncogenes; D014178:Translocation, Genetic